HNB
IMVT icon

Huntington National Bank’s Immunovant IMVT Stock Holding History

Huntington National Bank’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47K Hold
116
– – ﹤0.01% 2279
2026
Q1 		$2.88K Hold
116
– – ﹤0.01% 2194
2025
Q4 		$2.95K Buy
+116
New +$2.59K ﹤0.01% 2118
2025
Q2 		– Sell
-158
Closed -$2.7K – 4190
2025
Q1 		$2.7K Buy
+158
New +$3.31K ﹤0.01% 2153

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Huntington National Bank's IMVT Position: Q2 2026 in Review

Huntington National Bank held its Immunovant (IMVT) position steady in Q2 2026 at 116 shares worth $4.47K. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Huntington National Bank first reported a position in IMVT in Q1 2025 and has held it in 4 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Huntington National Bank held 116 shares of Immunovant worth $4.47K as of Q2 2026.
  • Huntington National Bank left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2279 holding.
  • Huntington National Bank first reported a position in Immunovant in Q1 2025 and has held it in 4 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.